HCID 42645536, compound → HCID 42645535, compound
Reaction equation
[Cl:1][C:2]1[CH:7]=[CH:6][C:5](/[CH:8]=[C:9](/[S:11]([NH:14][C:15]2[CH:20]=[C:19]([F:21])[CH:18]=[CH:17][C:16]=2[S:22]([NH2:25])(=[O:24])=[O:23])(=[O:13])=[O:12])\[CH3:10])=[CH:4][CH:3]=1>C(OCC)(=O)C>[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([CH2:8][CH:9]([S:11]([NH:14][C:15]2[CH:20]=[C:19]([F:21])[CH:18]=[CH:17][C:16]=2[S:22]([NH2:25])(=[O:24])=[O:23])(=[O:12])=[O:13])[CH3:10])=[CH:4][CH:3]=1Participants
3
Reactant 1
Product 1
Reagents, catalysts & solvents 1
Procedure
2-[[(E)-1-(4-Chlorophenyl)prop-1-en-2-yl]sulfonylamino]-4-fluoro-benzenesulfonamide (60 mg, 0.15 mmol) was dissolved in ethyl acetate (3 mL) and mixture was subjected to reduction using the H-cube instrument. The reaction mixture was eluted through the Pd/C (10%) cartridge using full hydrogen (1 atm) at 1 ml/min. The mixture was subjected to the H-cube once again using the same conditions. The crude product was purified by preparative HPLC (XTerra MS C8 column, acetonitrile/ammonium acetate buffer) to give the title compound (25 mg, 38%).
Workup
- washThe reaction mixture was eluted through the Pd/C (10%) cartridge
- customThe crude product was purified by preparative HPLC (XTerra MS C8 column, acetonitrile/ammonium acetate buffer)
Sources & evidence
- ORD record
- ord-1543b3a982c044c6820594b53bf41e81
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09145380B2
Reaction notes
Loading…